Bijoy Hans Limited Receives BSE Listing Approval for 4.05 Crore Equity Shares Issued on Preferential Basis

1 min read     Updated on 03 Apr 2026, 05:32 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Bijoy Hans Limited received BSE listing approval for 4,05,21,836 equity shares of Rs. 10 each issued at Rs. 12.50 per share on preferential basis to promoters and non-promoters. The approval was granted on April 02, 2026, with shares bearing distinctive numbers from 75,00,022 to 4,80,21,857. BSE has outlined specific compliance requirements including NSDL/CDSL confirmations and potential NSE approval before granting trading approval, with a seven-day timeline for trading approval application as per SEBI regulations.

powered bylight_fuzz_icon
36763350

*this image is generated using AI for illustrative purposes only.

Bijoy Hans Limited has secured listing approval from BSE for its preferential issue of equity shares, marking a significant corporate development for the company. The approval encompasses a substantial number of shares issued to both promoters and non-promoters.

Share Issue Details

The company received BSE's formal approval for listing 4,05,21,836 equity shares through a preferential allotment. The key parameters of this share issue are presented below:

Parameter: Details
Number of Shares: 4,05,21,836
Face Value: Rs. 10 per share
Premium: Rs. 2.50 per share
Issue Price: Rs. 12.50 per share
Distinctive Numbers: 75,00,022 to 4,80,21,857
Allottees: Promoters and non-promoters

Regulatory Compliance and Approval Process

BSE granted the listing approval vide letter reference LOD/PREF/DA/FIP/17/2026-27 dated April 02, 2026. The company communicated this development to BSE on April 03, 2026, in compliance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.

The exchange has emphasized compliance with Regulation 167 of SEBI (ICDR) Regulations and other SEBI specifications. Additionally, if the change exceeds two percent of the total paid-up share capital, the company must file the shareholding pattern in XBRL mode as required under Regulation 31(1)(c) of SEBI LODR Regulations, 2015.

Trading Approval Requirements

BSE has specified several prerequisites before granting trading approval for the newly listed shares:

  • Listing approval from National Stock Exchange of India Ltd. (if applicable)
  • Confirmation letters from NSDL/CDSL regarding crediting shares to beneficiary accounts
  • Confirmation about admitting the capital to the depository system
  • Confirmation letters regarding lock-in of pre-preferential holding (if applicable)

Timeline and Compliance Obligations

According to SEBI circular SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023, listed entities must apply for trading approval within seven working days from the date of listing approval grant. Non-compliance with this requirement will attract penalties as specified in the circular.

The approval letter was signed by Marian D'souza, Assistant Vice President, and Dhananjay Apte, Deputy Manager at BSE, confirming the exchange's formal consent for the listing of these preferential shares.

How will the preferential allotment impact Bijoy Hans Limited's promoter shareholding pattern and control structure?

What strategic initiatives or expansion plans does the company intend to fund with the Rs. 50.65 crore raised through this preferential issue?

Will the dilution from 4.05 crore new shares affect the company's earnings per share and market valuation in the near term?

like18
dislike

Bijoy Hans Limited Issues Postal Ballot Notice for Name Change to Arvaya Healthcare

2 min read     Updated on 19 Mar 2026, 06:17 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Bijoy Hans Limited has issued a comprehensive postal ballot notice seeking shareholder approval for multiple corporate restructuring initiatives including name change to Arvaya Healthcare Limited, enhanced financial authorizations of ₹200 crores, executive appointments with ₹10 lakh monthly remuneration, and capital structure expansion from ₹60 crores to ₹200 crores authorized share capital through electronic voting process.

powered bylight_fuzz_icon
34882688

*this image is generated using AI for illustrative purposes only.

Bijoy Hans Limited issued a comprehensive postal ballot notice on March 19, 2026, seeking shareholder approval for multiple corporate restructuring initiatives previously approved by the board of directors on March 17, 2026. The notice outlines nine special resolutions requiring member consent through electronic voting.

Corporate Name Change Process

The company is pursuing a strategic name change from "Bijoy Hans Limited" to "Arvaya Healthcare Limited" to better align with its healthcare business focus. Notably, the postal ballot includes withdrawal of a previously approved name "Arvaya Healthtech Limited" that was sanctioned at an extraordinary general meeting on February 25, 2026.

Name Change Process: Details
Current Name: Bijoy Hans Limited
Previously Approved Name: Arvaya Healthtech Limited (to be withdrawn)
Proposed New Name: Arvaya Healthcare Limited
Regulatory Approval: Ministry of Corporate Affairs approved

Financial Authorization Enhancements

The postal ballot seeks approval for substantial increases in financial limits to support business expansion:

Financial Authorizations: Proposed Limits Legal Framework
Borrowing Limits: ₹200 crores Section 180(1)(c) of Companies Act, 2013
Loans, Guarantees & Investments: ₹200 crores Section 186 of Companies Act, 2013
Related Party Transactions: ₹100 crores Section 185 of Companies Act, 2013

Leadership Structure Changes

Significant executive appointments and remuneration revisions require shareholder approval:

Leadership Changes: Details Monthly Remuneration
Managing Director Kaushal Shah: Remuneration revision ₹10.00 lakhs
Salil Shetty: Non-Executive to Executive Director & CEO ₹10.00 lakhs
Tenure: CEO appointment period April 1, 2026 to March 31, 2031

Capital Structure Expansion

The company proposes fundamental changes to its authorized share capital structure:

Capital Structure: Current Proposed
Authorized Share Capital: ₹60 crores ₹200 crores
Equity Shares: 6 crore shares of ₹10 each 20 crore shares of ₹10 each
Articles of Association: Existing framework Updated for Companies Act, 2013 compliance

E-Voting Process and Timeline

The postal ballot will be conducted exclusively through electronic voting, with NSDL providing the e-voting platform. Mr. Chinmay Mohan Lele, Practicing Company Secretary (FCS 12351; CP: 28362), has been appointed as Scrutinizer to ensure fair and transparent proceedings.

Voting Schedule: Date & Time
Cut-off Date: March 13, 2026
E-voting Commencement: March 21, 2026 at 9:00 AM IST
E-voting Conclusion: April 19, 2026 at 5:00 PM IST
Result Declaration: On or before April 21, 2026

The postal ballot notice has been sent electronically to shareholders whose email addresses are registered with the company's registrar, Maheshwari Datamatics Private Limited, and depositories NSDL and CDSL. Results will be uploaded on stock exchanges within two working days of conclusion and published on the company website at https://www.bijoyhans.net/ and NSDL's e-voting portal.

How will the significant increase in authorized share capital from ₹60 crores to ₹200 crores impact existing shareholders' ownership dilution in future fundraising rounds?

What specific healthcare sector acquisitions or expansion plans might justify the substantial ₹200 crore increase in borrowing and investment limits?

Will the leadership transition with Salil Shetty becoming CEO signal a strategic pivot in the company's healthcare business model or market focus?

like17
dislike

More News on Bijoy Hans Limited